The project combines three approaches:
Structure Survey – Country-level mapping of residency structures.
Resident Survey – Perspectives from residents and young specialists on preparedness, workload, satisfaction, and career outlook.
Curricula and Literature Analysis – Comparing national curricula with WFME standards and reviewing published studies on pediatric training.
Together, these studies will provide the first comprehensive picture of paediatric residency training across the European region. Findings will be published in peer-reviewed journals and country-reports shared with national pediatric societies and European institutions to drive improvements in training and working conditions.
The study is conducted by the Young European Academy of Paediatrics (YEAP), the official pediatric section of the European Union of Medical Specialists (UEMS).
Paed-STEP will deliver the first comprehensive evidence base to guide harmonisation and policy action.
Four complementary components:
Led by trainees, for trainees: YEAP coordinates across 26+ European countries, ensuring the resident voice is central.
Policy relevance: findings will directly inform EAP, UEMS, national societies, and European institutions.
Launch September 2025 → results early 2026
Launch October 2025 → fielding until May 2026
Document collection and analysis September 2025- May 2026
Literature search and synthesis through 2026
Dissemination : end of 2026 through 2027
New ways to test high-risk medical devices.
Manufacturers of medical devices need to test their products before being allowed to market them. Specifically, they require clinical data showing their medical device is safe and efficient. In this context, the EU-funded CORE-MD project will translate expert scientific and clinical evidence on study designs for evaluating high-risk medical devices into advice for EU regulators. The project will propose how new trial designs can contribute and suggest ways to aggregate real-world data from medical device registries.
It will also conduct multidisciplinary workshops to propose a hierarchy of levels of evidence from clinical investigations, as well as educational and training objectives for all stakeholders, to build expertise in regulatory science in Europe. CORE–MD will translate expert scientific and clinical evidence on study designs for evaluating high-risk medical devices into advice for EU regulators, to achieve an appropriate balance between innovation, safety, and effectiveness. A unique collaboration between medical associations, regulatory agencies, notified bodies, academic institutions, patients’ groups, and health technology assessment agencies, will systematically review methodologies for the clinical investigation of high-risk medical devices, recommend how new trial designs can contribute, and advise on methods for aggregating real-world data from medical device registries with experience from clinical practice The consortium is led by the European Society of Cardiology and the European Federation of National Associations of Orthopaedics and Traumatology, and involves all 33 specialist medical associations that are members of the Biomedical Alliance in Europe.
